#YonhapInfomax #GileadSciences #EarningsGuidance #NetLoss #ResearchAndDevelopment #AfterHoursTrading #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=119467

Gilead Sciences Swings to Loss in Annual Guidance, Shares Fall 1.5% After Hours
Gilead Sciences shares dropped 1.5% after hours as the pharmaceutical giant slashed its full-year guidance to a net loss of $0.65-$1.05 per share from previous profit expectations of $8.45-$8.85, citing increased R&D and financing costs from recent major transactions.


Felis Floppus






